Pattern of antiepileptic drug-induced cell death in limbic regions of the neonatal rat brain - PubMed
Pattern of antiepileptic drug-induced cell death in limbic regions of the neonatal rat brain
Patrick A Forcelli et al. Epilepsia. 2011 Dec.
Abstract
The induction of neuronal apoptosis throughout many regions of the developing rat brain by phenobarbital and phenytoin, two drugs commonly used for the treatment of neonatal seizures, has been well documented. However, several limbic regions have not been included in previous analyses. Because drug-induced damage to limbic brain regions in infancy could contribute to emotional and psychiatric sequelae, it is critical to determine the extent to which these regions are vulnerable to developmental neurotoxicity. To evaluate the impact of antiepileptic drug (AED) exposure on limbic nuclei, we treated postnatal day 7 rat pups with phenobarbital, phenytoin, carbamazepine, or vehicle, and examined nucleus accumbens, septum, amygdala, piriform cortex, and frontal cortex for cell death. Histologic sections were processed using the terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) assay to label apoptotic cells. Nucleus accumbens displayed the highest level of baseline cell death (vehicle group), as well as the greatest net increase in cell death following phenobarbital or phenytoin. Phenobarbital exposure resulted in a significant increase in cell death in all brain regions, whereas phenytoin exposure increased cell death only in the nucleus accumbens. Carbamazepine was without effect on cell death in any brain region analyzed, suggesting that the neurotoxicity observed is not an inherent feature of AED action. Our findings demonstrate pronounced cell death in several important regions of the rat limbic system following neonatal administration of phenobarbital, the first-line treatment for neonatal seizures in humans. These findings raise the possibility that AED exposure in infancy may contribute to adverse neuropsychiatric outcomes later in life.
Wiley Periodicals, Inc. © 2011 International League Against Epilepsy.
Conflict of interest statement
Disclosure of Conflicts of Interest:
None of the authors has any conflict of interest to disclose. “We confirm that we have read the Journal’s position on issues involved in ethical publication and affirm that this report is consistent with those guidelines.”
Figures

Representative photomicrographs of TUNEL-stained sections for each brain region from animals treated with: vehicle (control) (a, e, i, m, q), phenobarbital (b, f, j, n, r), phenytoin (c, g, k, o, s), and carbamazepine (d, h, l, p, t). Dotted lines illustrate anatomical boundaries. TUNEL positive cells are stained brown. Scale bar = 250µm. AC = anterior commissure, LV = lateral ventricle, Ce = Central amygdala, BL = basal and lateral amygdala, EC = external capsule, Roman numerals I to IV = cortical layers one to five. See Figure 2 for schematic representations of brain regions.

Quantification of cell death. (a) Baseline levels of cell death following vehicle (control). (b) Net increase (over baseline cell death, as presented in Figure 2a) for each brain area and drug treatment. * = significantly different than baseline levels of cell death, P<0.05. Schematics are modified from the atlas of Sherwood and Timiras (1970). Photomicrograph (10x) of nucleus accumbens with the inset showing TUNEL-positive cells (40x, indicated by white arrowhead).
Similar articles
-
Katz I, Kim J, Gale K, Kondratyev A. Katz I, et al. J Pharmacol Exp Ther. 2007 Aug;322(2):494-500. doi: 10.1124/jpet.107.123133. Epub 2007 May 4. J Pharmacol Exp Ther. 2007. PMID: 17483293
-
Kim J, Kondratyev A, Gale K. Kim J, et al. J Pharmacol Exp Ther. 2007 Oct;323(1):165-73. doi: 10.1124/jpet.107.126250. Epub 2007 Jul 16. J Pharmacol Exp Ther. 2007. PMID: 17636003
-
Anticonvulsant drug-induced cell death in the developing white matter of the rodent brain.
Kaushal S, Tamer Z, Opoku F, Forcelli PA. Kaushal S, et al. Epilepsia. 2016 May;57(5):727-34. doi: 10.1111/epi.13365. Epub 2016 Mar 25. Epilepsia. 2016. PMID: 27012547 Free PMC article.
-
Antiepileptic drugs as prophylaxis for post-craniotomy seizures.
Weston J, Greenhalgh J, Marson AG. Weston J, et al. Cochrane Database Syst Rev. 2015 Mar 4;(3):CD007286. doi: 10.1002/14651858.CD007286.pub3. Cochrane Database Syst Rev. 2015. PMID: 25738821 Updated. Review.
-
Antiepileptic drugs as prophylaxis for post-craniotomy seizures.
Pulman J, Greenhalgh J, Marson AG. Pulman J, et al. Cochrane Database Syst Rev. 2013 Feb 28;(2):CD007286. doi: 10.1002/14651858.CD007286.pub2. Cochrane Database Syst Rev. 2013. PMID: 23450575 Updated. Review.
Cited by
-
Psychopathology in pediatric epilepsy: role of antiepileptic drugs.
Caplan R. Caplan R. Front Neurol. 2012 Dec 7;3:163. doi: 10.3389/fneur.2012.00163. eCollection 2012. Front Neurol. 2012. PMID: 23233847 Free PMC article.
-
Neuropathological sequelae of developmental exposure to antiepileptic and anesthetic drugs.
Turski CA, Ikonomidou C. Turski CA, et al. Front Neurol. 2012 Aug 1;3:120. doi: 10.3389/fneur.2012.00120. eCollection 2012. Front Neurol. 2012. PMID: 23015798 Free PMC article.
-
An Update on Maternal Use of Antiepileptic Medications in Pregnancy and Neurodevelopment Outcomes.
Gerard EE, Meador KJ. Gerard EE, et al. J Pediatr Genet. 2015 Jun;4(2):94-110. doi: 10.1055/s-0035-1556741. J Pediatr Genet. 2015. PMID: 27617120 Free PMC article. Review.
-
Ryan MAJ, Malhotra A. Ryan MAJ, et al. Pediatr Res. 2024 Sep;96(4):896-904. doi: 10.1038/s41390-024-03207-2. Epub 2024 Apr 29. Pediatr Res. 2024. PMID: 38684885 Free PMC article. Review.
-
Cognitive outcomes of prenatal antiepileptic drug exposure.
Inoyama K, Meador KJ. Inoyama K, et al. Epilepsy Res. 2015 Aug;114:89-97. doi: 10.1016/j.eplepsyres.2015.04.016. Epub 2015 May 2. Epilepsy Res. 2015. PMID: 26088891 Free PMC article. Review.
References
-
- Dobbing J, Sands J. Comparative aspects of the brain growth spurt. Early Hum Dev. 1979;3:79–83. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- T32 NS041231/NS/NINDS NIH HHS/United States
- F31 NS066822-02/NS/NINDS NIH HHS/United States
- K01 MH002040-01/MH/NIMH NIH HHS/United States
- T32 NS041231-09/NS/NINDS NIH HHS/United States
- R01 NS020576-11/NS/NINDS NIH HHS/United States
- R01 NS020576/NS/NINDS NIH HHS/United States
- F31 NS066822/NS/NINDS NIH HHS/United States
- MH02040/MH/NIMH NIH HHS/United States
- T32DA007291/DA/NIDA NIH HHS/United States
- NS20576/NS/NINDS NIH HHS/United States
- T32NS041231/NS/NINDS NIH HHS/United States
- F31 NS066822-01/NS/NINDS NIH HHS/United States
- F31NS066822/NS/NINDS NIH HHS/United States
- K01 MH002040/MH/NIMH NIH HHS/United States
- T32 DA007291/DA/NIDA NIH HHS/United States
LinkOut - more resources
Full Text Sources